P Hovind, L Tarnow, P Rossing, BR Jensen, M … - British Medical Journal, 2004 - bmj.com You are seeing this message because your web browser does not support basic web
standards. Find out more about why this message is appearing and what you can do
to make your experience on this site better. ... Objective To evaluate ... Cited by 128 - Related articles - BL Direct - All 8 versions
- ►endojournals.org BF Schrijvers, AS De Vriese, A Flyvbjerg - Endocrine reviews, 2004 - Endocrine Soc At present, diabetic kidney disease affects about 15–25% of type 1 and
30–40% of type 2 diabetic patients. Several decades of extensive research has
elucidated various pathways to be implicated in the development of diabetic ... Cited by 120 - Related articles - All 5 versions
- ►nih.gov KI Rother, DM Harlan - Journal of Clinical Investigation, 2004 - Am Soc Clin Investig Worldwide, more than 750 individuals with type 1 diabetes mellitus (T1DM) have
received allogeneic islet transplants since 1974, in an effort to cure their
chronic condition. Though this is still a small number (especially when ... Cited by 103 - Related articles - BL Direct - All 11 versions
DA Antonetti, AJ Barber, SK Bronson, WM … - Diabetes, 2006 - Am Diabetes Assoc Diabetic retinopathy remains a frightening prospect to patients and frustrates
physicians. Destruction of damaged retina by photocoagulation remains the
primary treatment nearly 50 years after its introduction. The diabetes ... Cited by 73 - Related articles - BL Direct - All 9 versions
- ►shouxi.net G Pambianco, T Costacou, D Ellis, DJ Becker, … - Diabetes, 2006 - Am Diabetes Assoc Declining incidences in Europe of overt nephropathy, proliferative retinopathy,
and mortality in type 1 diabetes have recently been reported. However,
comparable data for the US and trend data for neuropathy and macrovascular ... Cited by 66 - Related articles - BL Direct - All 11 versions
- ►diabetesjournals.org M Nieuwdorp, HL Mooij, J Kroon, B Atasever, … - Diabetes, 2006 - Am Diabetes Assoc Chronic hyperglycemia underlies microvascular complications in patients with
type 1 diabetes. The mechanisms leading to these vascular complications are not
fully understood. Recently, we observed that acute hyperglycemia results in ... Cited by 55 - Related articles - BL Direct - All 8 versions
- ►bmj.com SM Marshall - British Medical Journal, 2004 - pmj.bmj.com Diabetic nephropathy is the leading cause of end stage renal disease worldwide
and is associated with increased cardiovascular risk. The earliest clinical
manifestation is of microalbuminuria. Tight blood glucose and blood ... Cited by 53 - Related articles - BL Direct - All 11 versions
- ►pubget.com [PDF] M Nordwall, M Bojestig, HJ Arnqvist, J … - Diabetologia, 2004 - Springer Aims/hypothesis. In a previous study conducted over the last decades we found a
decreased incidence of nephropathy but unchanged incidence of severe reti-
nopathy among patients with Type 1 diabetes diag- nosed in childhood and ... Cited by 51 - Related articles - BL Direct - All 6 versions
- ►diabetesjournals.org AP Boright, AD Paterson, L Mirea, SB Bull, A … - Diabetes, 2005 - Am Diabetes Assoc The development and progression of microvascular complications have been
extensively documented in a cohort of type 1 diabetic subjects enrolled in the
Diabetes Control and Complications Trial (DCCT) and followed in the ... Cited by 46 - Related articles - All 6 versions
- ►physiology.org SI Chisalita, HJ Arnqvist - American Journal of Physiology- Endocrinology And …, 2004 - Am Physiological Soc Micro- and macroangiopathy are major causes of morbidity and mortality in
patients with diabetes. Our aim was to characterize IGF-I receptor (IGF-IR) and
insulin receptor (IR) in human micro- and macrovascular endothelial cells. ... Cited by 39 - Related articles - BL Direct - All 5 versions
